Christabel Hikaambo

 

Christabel Hikaambo

Christabel obtained her Bachelor’s degree in Pharmacy(BPharm) from the University of Zambia in 2015 and emerged as the best student in her class. In the same year, she was awarded a Korean government scholarship to pursue her Master’s degree in South Korea. She graduated from Sookmyung Women’s University in South Korea in 2018 with a Master’s degree in Pharmacy(MPharm) majoring in Pharmaceutical chemistry. Her project work was based on the Synthesis of enantiomerically pure (d)–doxylamine using a novel chiral auxiliary. From 2019-2021, she served as a lecturer and researcher of pharmaceutical chemistry, medicinal chemistry and pharmacology in the department of pharmacy at the University of Zambia. She was also actively involved in the supervision of undergraduate final year research projects. In 2021, she acquired a Postgraduate diploma in Student research supervision and ethics from the University of Lusaka.
Currently, she is pursuing her PhD in medicinal chemistry under the supervision of Prof. Kelly Chibale and Drs. Kathryn Wicht and John Woodland. Her project is focused on exploring polypharmacology of Plasmodium kinase inhibitors via a targeted covalent inhibitor (TCI) approach. Once she graduates, she hopes to spearhead the establishment of a functional medicinal chemistry laboratory under the department of pharmacy at the University of Zambia. This will act as a driver for drug discovery and development research with students in Zambia.

 
 

 

Ferdinand Ndubi

 

 

 

 

Ferdinand Ndubi

Ferdinand is a trained pharmacist, having graduated with a Bachelor of Pharmacy (B.Pharm) degree from the University of Nairobi in Kenya in 2010. After a short stint as a practising pharmacist, he joined the University of Cape Town in 2014 for a MSc degree in Chemistry under the supervision of Prof. Kelly Chibale and Prof. Mino Caira. His MSc research involved synthesis, supramolecular derivatization, and pharmacological evaluation of antimalarial pyridobenzimidazoles to optimise their antimalarial activity and physico-chemical properties. He obtained his MSc in 2016. Since then he has been serving as lecturer and researcher at the department of pharmaceutical chemistry, school of pharmacy, Kabarak University in Kenya.
Currently, he is enrolled as a  PhD student under the supervision of Prof. Chibale and Drs. John Woodland and Kathryn Wicht. His research interest covers the broad area of drug discovery and development, specifically in the area of malaria as well as other neglected tropical diseases. Having worked as a hospital pharmacist in Kenya, he is has seen first-hand the challenges associated with inadequate safe and efficacious treatment options for malaria. He hopes to utilise his PhD studies and future research efforts to contribute to the discovery and development of novel safe and effective treatment options for neglected tropical diseases.
His research interests include drug metabolism and CYP enzyme kinetics as well as the broader field of pharmacokinetics. He has a great interest in preclinical drug development with a specific focus of his to hopefully help in lowering the disease burden on the African continent.

​ ​